rs41115

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000038.6(APC):​c.4479G>A​(p.Thr1493=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.625 in 1,613,660 control chromosomes in the GnomAD database, including 318,158 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27967 hom., cov: 31)
Exomes 𝑓: 0.63 ( 290191 hom. )

Consequence

APC
NM_000038.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:18O:1

Conservation

PhyloP100: 0.0920
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 5-112840073-G-A is Benign according to our data. Variant chr5-112840073-G-A is described in ClinVar as [Benign]. Clinvar id is 42242.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112840073-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.092 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.799 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
APCNM_000038.6 linkuse as main transcriptc.4479G>A p.Thr1493= synonymous_variant 16/16 ENST00000257430.9 NP_000029.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
APCENST00000257430.9 linkuse as main transcriptc.4479G>A p.Thr1493= synonymous_variant 16/165 NM_000038.6 ENSP00000257430 P1P25054-1

Frequencies

GnomAD3 genomes
AF:
0.602
AC:
91324
AN:
151810
Hom.:
27950
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.534
Gnomad AMI
AF:
0.617
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.567
Gnomad EAS
AF:
0.820
Gnomad SAS
AF:
0.731
Gnomad FIN
AF:
0.537
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.613
Gnomad OTH
AF:
0.612
GnomAD3 exomes
AF:
0.650
AC:
162664
AN:
250358
Hom.:
53850
AF XY:
0.649
AC XY:
87950
AN XY:
135508
show subpopulations
Gnomad AFR exome
AF:
0.533
Gnomad AMR exome
AF:
0.734
Gnomad ASJ exome
AF:
0.582
Gnomad EAS exome
AF:
0.822
Gnomad SAS exome
AF:
0.713
Gnomad FIN exome
AF:
0.559
Gnomad NFE exome
AF:
0.619
Gnomad OTH exome
AF:
0.651
GnomAD4 exome
AF:
0.627
AC:
917207
AN:
1461732
Hom.:
290191
Cov.:
63
AF XY:
0.629
AC XY:
457710
AN XY:
727164
show subpopulations
Gnomad4 AFR exome
AF:
0.520
Gnomad4 AMR exome
AF:
0.727
Gnomad4 ASJ exome
AF:
0.582
Gnomad4 EAS exome
AF:
0.840
Gnomad4 SAS exome
AF:
0.709
Gnomad4 FIN exome
AF:
0.573
Gnomad4 NFE exome
AF:
0.616
Gnomad4 OTH exome
AF:
0.633
GnomAD4 genome
AF:
0.602
AC:
91393
AN:
151928
Hom.:
27967
Cov.:
31
AF XY:
0.603
AC XY:
44806
AN XY:
74264
show subpopulations
Gnomad4 AFR
AF:
0.535
Gnomad4 AMR
AF:
0.669
Gnomad4 ASJ
AF:
0.567
Gnomad4 EAS
AF:
0.820
Gnomad4 SAS
AF:
0.731
Gnomad4 FIN
AF:
0.537
Gnomad4 NFE
AF:
0.613
Gnomad4 OTH
AF:
0.610
Alfa
AF:
0.613
Hom.:
36825
Bravo
AF:
0.610
Asia WGS
AF:
0.753
AC:
2615
AN:
3476
EpiCase
AF:
0.610
EpiControl
AF:
0.612

ClinVar

Significance: Benign
Submissions summary: Benign:18Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 16, 2016- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJul 27, 2020The p.Thr1493Thr variant in APC is classified as benign because it has been identified in 82% (16364/19946) of East Asian chromosomes, including 6724 homozygotes, by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedresearchMayo Clinic Laboratories, Mayo Clinic-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Hereditary cancer-predisposing syndrome Benign:3
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 18, 2016- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 31, 2014This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, no assertion criteria providedclinical testingInstitute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C.Dec 21, 2021- -
Familial adenomatous polyposis 1 Benign:2
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Gastric cancer;C0346629:Colorectal cancer;C1851124:Desmoid disease, hereditary;C2239176:Hepatocellular carcinoma;C2713442:Familial adenomatous polyposis 1;C4749917:Gastric adenocarcinoma and proximal polyposis of the stomach Benign:1
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 24, 2022- -
APC-Associated Polyposis Disorders Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Carcinoma of colon Benign:1
Benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The c.4479G>A, p.Thr1493Thr variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located near a splice junction, and is listed in dbSNP (rs_id: rs41115) as a common polymorphism with a global minor allele frequency of 0.338. It has not been previously identified by our laboratory, but has been reported in the literature in 72/2142 (frequency of 0.033) proband chromosomes from individuals with familiar adenamatous polyposis, colorectal carcinoma, papillary thyroid carcinoma and sporadic ependymoma. It has also been identified in 54/2322 (frequency of 0.023) control chromosomes, increasing the likelihood that the variant has no clinical significance (Rocco_2006, Azzopardi_2008_18199528, Chao_2006_16569251, Curia_2012_21995949, Jasperson_2010_20420945, Kamory_2008_18369740, Onilude_2006_16843107, Schwab_2008_18026870, Subramaniam_2007_18024325, Teijeiro_2009_19095577). In summary, based on the above information, this variant is classified as benign. -
Familial colorectal cancer Other:1
other, no assertion criteria providedliterature onlySystems Biology Platform Zhejiang California International NanoSystems Institute-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
2.6
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41115; hg19: chr5-112175770; COSMIC: COSV57321403; COSMIC: COSV57321403; API